GBP2 enhances anti-PD-L1 response in colorectal cancer via GSDMD-mediated YAP nuclear translocation by non-pyroptotic. Nie H, Yu Y, Zhou J, Ning Y, et al. Oncogene 2026 May 11. doi: 10.1038/s41388-026-03816.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nie H, Yu Y, Zhou J, Ning Y, et al. GBP2 enhances anti-PD-L1 response in colorectal cancer via GSDMD-mediated YAP nuclear translocation by non-pyroptotic. Oncogene 2026 May 11. doi: 10.1038/s41388-026-03816.
PMID: 42115407